The use of corticosteroids for COVID-19 infection
Afr. j. med. med. sci
;
26(3): 1-3, 2020.
Artículo
en Inglés
| AIM
| ID: biblio-1257346
ABSTRACT
The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detrimental effects of corticosteroid therapy in general viral respiratory infections and, in particular, COVID-19 infections. While the definitive answer may need to await the results of ongoing randomised, controlled trials recent studies suggest that corticosteroid use in COVID-19 cases with hypoxaemia may benefit from low-dose corticosteroid therapy
Buscar en Google
Índice:
AIM (África)
Asunto principal:
Sudáfrica
/
Corticoesteroides
/
Infecciones por Coronavirus
/
Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo
/
COVID-19
Tipo de estudio:
Ensayo Clínico Controlado
/
Guía de Práctica Clínica
País/Región como asunto:
Africa
Idioma:
Inglés
Revista:
Afr. j. med. med. sci
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS